Support for use of psilocybin in medical trials and treatment U.S. 2017

Percentage of U.S. adults who supported allowing researchers to conduct medical trials with psilocybin as of 2017

Loading statistic...
Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date



North America, United States

Survey time period

June 2 to 5, 2017

Number of respondents

1,125 respondents

Age group

18 years and older

Special properties

U.S. adults

Supplementary notes

Original question: Psilocybin, the active ingredient in psychedelic mushrooms, has been illegal in the United States for more than 40 years. A recent study by researchers from New York University and Johns Hopkins University showed that a single treatment with Psilocybin reduced anxiety and depression in 80% of cancer patients. The effects of a single 8-hour session lasted up to 7 months, and had minimal side effects. Do you support or oppose similar medical trials with Psilocybin being conducted in the future?

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

Other statistics that may interest you Statistics on

About the industry


About the region


Other regions


Related statistics


Further related statistics

Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.